A new pharma candidate that Inhibits the formation of metastases.

A UK University has identified that sucralose can reduce the permeability of capillary walls, preventing the spread of cancer cells via the bloodstream, and inhibit the formation of blood vessels in new tissue, restricting tumour growth. It seeks partners to clinically trial and commercialise the product under at commercial agreement with technical assistance, a license agreement or a research cooperation agreement.

Type of partner sought: The university are seeking a commercial partner to take the work forward, with the aim of licensing or selling the IP as it moves towards a clinical trial.

Per maggiori informazioni clicca qui.

Sei interessato al profilo? Scrivi a een1@confindustria.lombardia.it